Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BioMarin Pharmaceutical Inc. is a global biotechnology company specializing in developing and commercializing therapies for rare genetic diseases. Its core products include enzyme replacement therapies and gene therapies targeting conditions like mucopolysaccharidosis, achondroplasia, phenylketonuria, Batten disease, and hemophilia A. BioMarin serves patients worldwide through direct sales and partnerships, leveraging proprietary biologics, gene therapy platforms, and a strong intellectual property portfolio to address unmet medical needs in specialized markets.
This description was generated via AI from an annual report. Updated about 1 year ago.